Showing results (91-100 of 119) with videos related to

Sort By:
Pageof 12
Nature|September 7, 2018
A homing system targets therapeutic T cells to brain cancerHeba Samaha, Antonella Pignata, Kristen Fousek, et al.
Blood Immunology & Cellular Therapy|June 26, 2026
Donor lymphocyte infusions after HCT are associated with low risk of graft-versus-host disease in pediatric and young adult patientsShruthi Suryaprakash, Yilun Sun, Dinesh Keerthi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 11, 2023
Posoleucel, an Allogeneic, Off-the-Shelf Multivirus-Specific T-Cell Therapy, for the Treatment of Refractory Viral Infections in the Post-HCT SettingThomas Pfeiffer, Ifigeneia Tzannou, Mengfen Wu, et al.
Hemasphere|December 10, 2025
Harmonization on defining B-cell recovery post CD19-CAR T-cell therapy in B-cell acute lymphoblastic leukemia: An international consensus statementAdam Lamble, Sandra D Bohling, Kara L Davis, et al.
Science Advances|January 10, 2025
Molecular dynamics at immune synapse lipid rafts influence the cytolytic behavior of CAR T cellsAhmed Z Gad, Jessica S Morris, Lea Godret-Miertschin, et al.
Cytotherapy|June 4, 2026
Successful autologous T cell apheresis in pediatric patients with hematologic malignancies, solid tumors, and brain tumorsDevin Murphy, Yu Bi, Aysha Patel, et al.
Cytotherapy|July 24, 2024
Safety and Efficacy of High-Dose Memory CD45RO+ Donor Lymphocyte Infusion in Pediatric Recipients after Hematopoietic Stem Cell TransplantationMercedes Gasior Kabat, Ying Li, Victor Galán, et al.
Blood|May 16, 2015
Inducible caspase-9 suicide gene controls adverse effects from alloreplete T cells after haploidentical stem cell transplantationXiaoou Zhou, Gianpietro Dotti, Robert A Krance, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 3, 2017
Outcomes after Allogeneic Transplant in Patients with Wiskott-Aldrich SyndromeAlexander Ngwube, I Celine Hanson, Jordan Orange, et al.
Haematologica|April 23, 2026
Novel KAT6B::NUTM2B fusion oncogene in congenital acute myeloid leukemia and implications for menin inhibitor therapyRebecca K Voss, Wenqing Qi, La'Ron Browne, et al.
Pageof 12